INDUCTION OF FOS-LIKE IMMUNOREACTIVITY IN HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR NEURONS AFTER ADRENALECTOMY IN THE RAT

被引:114
作者
JACOBSON, L
SHARP, FR
DALLMAN, MF
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,S-762,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1210/endo-126-3-1709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To identify brain sites responding to the removal of corticosterone feedback by adrenalectomy (ADX), rat brains were processed for fos immunocytochemistry 1, 3, and 7 days after ADX, sham-ADX, or no surgery using a polyclonal antiserum to fos residues 132-154. Compared to SHAM, ADX rats exhibited strong fos-like immunoreactivity (FLI) only in the parvocellular neurons of the paraventricular hypothalamic nuclei (PVN) 1, 3, and 7 days after surgery. Replacement with a corticosterone pellet at the time of adrenalectomy (ADX + B) prevented this increase in PVN FLI in three of four rats at 1 day, all rats at 3 days, and two of seven rats 7 days after surgery; 100 µg/ml corticosterone in the drinking water for 2 days before perfusion reversed ADX-induced increases in PVN FLI in 7-day ADX rats. Providing 25 µg/ml corticosterone in the drinking water to ADX rats for 5 days after surgery did not prevent expression of PVN FLI, even though this dose has been shown to normalize morning basal ACTH levels in ADX rats. Virtually all parvocellular PVN neurons expressing FLI after ADX costained for CRF. Some parvocellular neurons also expressed both fos and vasopressin. In all rats, many brain regions expressed FLI that was not related to adrenalectomy. We conclude that the changes in neuronal FLI correlate with demonstrated changes in neuroendocrine activity after ADX; however, suppression of ADX-induced FLI may require higher replacement levels of corticosterone than inhibition of ADX-induced ACTH secretion. © 1990 by The Endocrine Society.
引用
收藏
页码:1709 / 1719
页数:11
相关论文
共 48 条
[1]   CORTICOSTERONE - NARROW RANGE REQUIRED FOR NORMAL BODY AND THYMUS WEIGHT AND ACTH [J].
AKANA, SF ;
CASCIO, CS ;
SHINSAKO, J ;
DALLMAN, MF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 249 (05) :R527-R532
[2]   RESET OF FEEDBACK IN THE ADRENOCORTICAL SYSTEM - AN APPARENT SHIFT IN SENSITIVITY OF ADRENOCORTICOTROPIN TO INHIBITION BY CORTICOSTERONE BETWEEN MORNING AND EVENING [J].
AKANA, SF ;
CASCIO, CS ;
DU, JZ ;
LEVIN, N ;
DALLMAN, MF .
ENDOCRINOLOGY, 1986, 119 (05) :2325-2332
[3]   IMMUNOREACTIVE CORTICOTROPIN-RELEASING HORMONE IN THE HYPOTHALAMOINFUNDIBULAR TRACT [J].
ANTONI, FA ;
PALKOVITS, M ;
MAKARA, GB ;
LINTON, EA ;
LOWRY, PJ ;
KISS, JZ .
NEUROENDOCRINOLOGY, 1983, 36 (06) :415-423
[4]   GROWTH-FACTORS AND MEMBRANE DEPOLARIZATION ACTIVATE DISTINCT PROGRAMS OF EARLY RESPONSE GENE-EXPRESSION - DISSOCIATION OF FOS AND JUN INDUCTION [J].
BARTEL, DP ;
SHENG, M ;
LAU, LF ;
GREENBERG, ME .
GENES & DEVELOPMENT, 1989, 3 (03) :304-313
[5]   REGULATION OF THE MESSENGER RIBONUCLEIC-ACID FOR CORTICOTROPIN-RELEASING FACTOR IN THE PARAVENTRICULAR NUCLEUS AND OTHER BRAIN SITES OF THE RAT [J].
BEYER, HS ;
MATTA, SG ;
SHARP, BM .
ENDOCRINOLOGY, 1988, 123 (04) :2117-2122
[6]   THE C-FOS PROTEIN INTERACTS WITH C-JUN/AP-1 TO STIMULATE TRANSCRIPTION OF AP-1 RESPONSIVE GENES [J].
CHIU, R ;
BOYLE, WJ ;
MEEK, J ;
SMEAL, T ;
HUNTER, T ;
KARIN, M .
CELL, 1988, 54 (04) :541-552
[7]   PRESENCE OF GLUCOCORTICOID RECEPTOR IMMUNOREACTIVITY IN CORTICOTROPIN RELEASING-FACTOR AND IN GROWTH-HORMONE RELEASING-FACTOR IMMUNOREACTIVE NEURONS OF THE RAT DILENCEPHALON AND TELENCEPHALON [J].
CINTRA, A ;
FUXE, K ;
HARFSTRAND, A ;
AGNATI, LF ;
WIKSTROM, AC ;
OKRET, S ;
VALE, W ;
GUSTAFSSON, JA .
NEUROSCIENCE LETTERS, 1987, 77 (01) :25-30
[8]   FRA-1 - A SERUM-INDUCIBLE, CELLULAR IMMEDIATE-EARLY GENE THAT ENCODES A FOS-RELATED ANTIGEN [J].
COHEN, DR ;
CURRAN, T .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (05) :2063-2069
[9]   VIRAL AND CELLULAR FOS PROTEINS ARE COMPLEXED WITH A 39,000-DALTON CELLULAR PROTEIN [J].
CURRAN, T ;
VANBEVEREN, C ;
LING, N ;
VERMA, IM .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (01) :167-172
[10]  
Curran T, 1988, ONCOGENE HDB, P307